Your browser doesn't support javascript.
loading
Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer.
Lu, Mengmeng; Zhang, Xiaokang; Gao, Xiaoge; Sun, Shishuo; Wei, Xiaohuan; Hu, Xiaolei; Huang, Chao; Xu, Heng; Wang, Bixi; Zhang, Wei; Li, Zhen; Feng, Xinhui; Zheng, Junnian; Zhang, Qing.
Afiliación
  • Lu M; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Zhang X; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Gao X; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Sun S; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Wei X; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Hu X; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Huang C; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Xu H; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Wang B; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Zhang W; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Li Z; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Feng X; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China.
  • Zheng J; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, PR China. Electronic address: jnzheng@xzhmu.edu.cn.
  • Zhang Q; Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, PR China. Electronic address: qingzhang@xzhmu.edu.cn.
Pharmacol Res ; 174: 105829, 2021 12.
Article en En | MEDLINE | ID: mdl-34411731

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Inhibidores de Proteínas Quinasas / Receptores Quiméricos de Antígenos / Inmunosupresores / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Inhibidores de Proteínas Quinasas / Receptores Quiméricos de Antígenos / Inmunosupresores / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article